Evidence map›Paper›PMID 40109296›Full record

ArticleFrontiers in cardiovascular medicine2025

Corrigendum: Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure.

Alaa Rahhal, Tahseen Hamamyh, Ammar Chapra, Khaled J Zaza, Mostafa Najim, Mohammad Hemadneh, Hazem Faraj, Wael Kanjo, Ahmed Yasin, Haneen Toba and 10 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Alaa RahhalPharmacy Department, Hamad Medical Corporation, Doha, Qatar.
Tahseen HamamyhCardiology Department, Hamad Medical Corporation, Doha, Qatar.
Ammar ChapraCardiology Department, Hamad Medical Corporation, Doha, Qatar.
Khaled J ZazaAnesthesiology, Intensive Care and Perioperative Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Mostafa NajimInternal Medicine Department, Rochester Regional Health, New York, NY, United States.
Mohammad HemadnehInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Hazem FarajInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Wael KanjoInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Ahmed YasinInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Haneen TobaInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Wafa MohammedInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Mohammad Khair HamadEndocrinology Department, Hamad Medical Corporation, Doha, Qatar.
Nawras Al-TikretyInternal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Mhd Baraa HabibCardiology Department, Hamad Medical Corporation, Doha, Qatar.
Ahmed AwaisuDepartment of Clinical Pharmacy and Practice, Qatar University, Doha, Qatar.
Ahmed MahfouzPharmacy Department, Hamad Medical Corporation, Doha, Qatar.
Sumaya AlyafeiPharmacy Department, Hamad Medical Corporation, Doha, Qatar.
Abdul Rahman ArabiInterventional Cardiology Department, Hamad Medical Corporation, Doha, Qatar.
Ashfaq PatelHeart Failure Department, Hamad Medical Corporation, Doha, Qatar.
Mohammed Al-HijjiInterventional Cardiology Department, Hamad Medical Corporation, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fcvm.2024.1383669.].

Indexed as

acute coronary syndromecardioprotectionheart failureHF hospitalizationsodium–glucose cotransporter-2 (SGLT-2) inhibitors

Identifiers

PMID40109296
PMCPMC11920874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.